导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 32.27% | 426/4982 |
| 近一周 | -2.08% | 2082/5419 |
| 近一月 | -9.88% | 5139/5423 |
| 近一季 | -10.37% | 3013/5358 |
| 近半年 | 29.88% | 324/5131 |
| 近一年 | 30.43% | 630/4733 |
| 近两年 | 208.75% | 171/4208 |
| 近三年 | 153.11% | 170/3661 |
| 成立以来 | 780.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.04% 4257/5130 |
101.03% 155/5464 |
- - |
- - |
| 2025 | 38.03% 1603/5130 |
2.86% 2564/4624 |
1.57% 2563/4802 |
51.22% 360/4970 |
-12.63% 4644/5130 |
| 2024 | 39.74% 30/4618 |
-10.58% 3604/4340 |
3.50% 571/4442 |
16.41% 670/4550 |
29.70% 13/4618 |
| 2023 | -10.73% 1162/4216 |
14.73% 124/3759 |
-10.82% 3407/3909 |
-13.86% 3208/4055 |
1.29% 316/4209 |
| 2022 | -35.25% 2591/3578 |
-20.91% 2127/2804 |
2.24% 2418/3205 |
-19.88% 3012/3430 |
-0.06% 1529/3570 |
| 2021 | 32.36% 129/2717 |
-9.86% 1444/1745 |
40.75% 19/2232 |
0.61% 618/2560 |
3.69% 872/2708 |
| 2020 | 45.42% 665/1596 |
11.88% 49/1036 |
32.32% 185/1256 |
-11.35% 1239/1472 |
10.81% 1011/1690 |
| 2019 | 97.12% 4/926 |
34.37% 211/3054 |
-5.73% 2647/3201 |
30.04% 5/939 |
19.66% 26/1014 |
| 2018 | -23.64% 261/668 |
- - |
- - |
- - |
-13.78% 2619/2977 |
| 2017 | 26.10% 101/531 |
- - |
- - |
- - |
- - |
| 2016 | -18.71% 277/455 |
- - |
- - |
- - |
- - |
| 2015 | 62.61% 103/433 |
- - |
- - |
- - |
- - |
| 2014 | 18.84% 266/432 |
- - |
- - |
- - |
- - |
| 2013 | 38.84% 30/398 |
- - |
- - |
- - |
- - |
| 2012 | 18.76% 12/459 |
- - |
- - |
- - |
- - |
| 2011 | -18.06% 71/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 银河创新成长混合A VS. 长安宏观策略混合A(740001) |